Regentide-041 and composition comprising Regentide-041 for improving skin condition
AssigneeNinebiopharm Co., Ltd.
InventorsJae Hwan Kim, Ji Heon Rhim, Hye In Ahn, Ri Ra Lee, Hae Yeong Kang
Life of this patent
Estimating the term…
Abstract
The present invention relates to Regentide-041 and, more specifically, to a use of Regentide-041 for improving skin conditions. Regentide-041 according to the present invention is free of cytotoxicity and has remarkable effects of skin aging reduction, skin regeneration, skin elasticity improvement, skin wrinkle prevention, skin wrinkle reduction, and skin wound recovery and as such, can be variously utilized in the pharmaceutical, medicinal, cosmetic, and food fields.
Claims5
A method for skin condition improvement, the method comprising a step of administering a composition comprising a peptide represented by the amino acid sequence of SEQ ID NO:
- 1, wherein the skin condition improvement is one or more kinds selected from the group consisting of skin aging improvement, skin regeneration, skin elasticity improvement, skin wrinkle prevention, skin wrinkle improvement, and skin wound regeneration.
Dependencies are inferred from the claim text.